Pages that link to "Q27683156"
Jump to navigation
Jump to search
The following pages link to Receptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virus (Q27683156):
Displaying 50 items.
- Dynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane Fusion (Q26772129) (← links)
- Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies (Q26823492) (← links)
- Advances in the development of influenza virus vaccines. (Q30372164) (← links)
- Pre-fusion structure of a human coronavirus spike protein. (Q30385177) (← links)
- The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin (Q30387177) (← links)
- Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Human-type Receptors, Conferring Potential for Increased Avidity (Q30396804) (← links)
- Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin (Q34863065) (← links)
- Structure of the apo anti-influenza CH65 Fab. (Q35063209) (← links)
- Structural basis for Marburg virus neutralization by a cross-reactive human antibody (Q35132751) (← links)
- Structure and receptor binding of the hemagglutinin from a human H6N1 influenza virus (Q35218525) (← links)
- Influenza virus antigenicity and broadly neutralizing epitopes (Q35685270) (← links)
- Design and Structure of an Engineered Disulfide-Stabilized Influenza Virus Hemagglutinin Trimer (Q35758670) (← links)
- Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody (Q35909991) (← links)
- Vaccine-elicited antibody that neutralizes H5N1 influenza and variants binds the receptor site and polymorphic sites (Q35910153) (← links)
- Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry (Q37085836) (← links)
- Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination (Q37635478) (← links)
- Computational de novo design of antibodies binding to a peptide with high affinity (Q38774145) (← links)
- Antibody Recognition of Immunodominant Vaccinia Virus Envelope Proteins (Q39167579) (← links)
- Tackling influenza with broadly neutralizing antibodies (Q39319893) (← links)
- A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus (Q39397313) (← links)
- Principles of Broad and Potent Antiviral Human Antibodies: Insights for Vaccine Design (Q40043685) (← links)
- The road to a more effective influenza vaccine: Up to date studies and future prospects (Q40060218) (← links)
- In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity (Q40201534) (← links)
- Unique Structural Features of Influenza Virus H15 Hemagglutinin (Q40244820) (← links)
- Global site-specific N-glycosylation analysis of HIV envelope glycoprotein. (Q40276435) (← links)
- Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice (Q40809960) (← links)
- Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus (Q41027323) (← links)
- Effect of Priming With Seasonal Influenza A(H3N2) Virus on the Prevalence of Cross-Reactive Hemagglutination-Inhibition Antibodies to Swine-Origin A(H3N2) Variants (Q41932736) (← links)
- Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem (Q41933744) (← links)
- A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. (Q45778868) (← links)
- An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers. (Q47212197) (← links)
- Structural insights into the design of novel anti-influenza therapies (Q48113181) (← links)
- Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture. (Q50308620) (← links)
- A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site. (Q52338900) (← links)
- A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin. (Q52611914) (← links)
- Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses. (Q55434508) (← links)
- A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. (Q55546673) (← links)
- Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy. (Q55689231) (← links)
- Passive immunization with influenza haemagglutinin specific monoclonal antibodies (Q56880027) (← links)
- Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants (Q56888351) (← links)
- Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice (Q57469949) (← links)
- Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies (Q58696897) (← links)
- Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses (Q59132925) (← links)
- Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans (Q59349975) (← links)
- Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus (Q59355857) (← links)
- Structural Basis for the Broad, Antibody-Mediated Neutralization of H5N1 Influenza Virus (Q59358407) (← links)
- Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry (Q60921896) (← links)
- IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody (Q60922046) (← links)
- Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses (Q61818413) (← links)
- Monomeric Intermediates Formed by Vesiculovirus Glycoprotein during Its Low-pH-induced Structural Transition (Q62056275) (← links)